Comparison of Nebulized Fentanyl, Midazolam and Dexmedetomidine as a Premedication in Pediatric Dental Surgeries
NCT ID: NCT04226885
Last Updated: 2021-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2019-03-01
2021-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Many drugs have been used as premedication to decrease anxiety , facilitate smooth induction and easy separation of children from their parents.
* This study was designed to evaluate and compare the effect and safety of nebulized either fentanyl, midazolam or nebulized dexmedetomidine as a sedative premedication prior to general anesthesia (GA) in outpatient pediatric dental surgeries.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment
NCT06097169
Oral Dexmedetomidine vs Midazoam For Premedication
NCT03357718
Propofol vs. Nasal Dexmedetomidine in Pediatric Agitation and Delirium
NCT06466915
Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics
NCT04678050
Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment
NCT03827408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Many drugs have been used as premedication to decrease anxiety , facilitate smooth induction and easy separation of children from their parents. The ideal premedication especially in children must be acceptable with rapid onset ,minimal side effects and with rapid postoperative recovery and return to alertness (5,6).
Fentanyl is a potent analgesic opioid with a rapid onset, and short duration of action (7). Midazolam is a short-acting benzodiazepine that has anxiolytic, amnestic, hypnotic, anticonvulsant and muscle relaxant actions (8,9). Dexmedetomidine is a selective α-2 adrenergic agonist that has both sedative and analgesic effects (10-12)
Preoperative sedation in children is usually administered via the rectal, oral sublingual, and intranasal routes with different degrees of patient acceptance.(13-18). Nebulized drug is an alternative method of sedation that is relatively easy to set up, without need for venipuncture, and is associated with high bioavailability of the drug (19,20).
This study was designed to evaluate and compare the effect and safety of nebulized either fentanyl, midazolam or nebulized dexmedetomidine as a sedative premedication prior to general anesthesia (GA) in outpatient pediatric dental surgeries. The primary end point is the time of sedation and level of sedation when the child is first seen in the operating room(OR) 30 minutes after using studied drugs, based on the Modified Observer's Assessment of Alertness/Sedation Scale(19). The secondary end points are parentral separation, tolerance to mask induction, reaction to intravenous cannulation, hemodynamic changes( systolic blood pressure, diastolic blood pressure and heart rate), sedation at emergence and wake-up behavior.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fentanyl
patients will be given nebulized fentanyl 2μg/kg body weight 30 min before surgery
fentanyl
nebulized fentanyl 2μg/kg body weigh
midazolam
The patients will be given nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.
midazolam
nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.
dexmedetomidine
The patients will be given nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.
dexmedetomidine
nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fentanyl
nebulized fentanyl 2μg/kg body weigh
midazolam
nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.
dexmedetomidine
nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Mohamed Medhat
lecture of anesthesia and surgical intensive care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine,Zagazig University
Zagazig, Zagazig, Elsharkia,egypt, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5742-3-12-2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.